The iQ Group Global secures worldwide license for Harvard
Affordable rapid multiplexed biomarker detection at the point-of-care for patients and practitioners...
Stay updated with breaking news from Oncotex Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Affordable rapid multiplexed biomarker detection at the point-of-care for patients and practitioners...
IQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
IQX Limited (NSX:IQX) is pleased to announce that OncoTEX Inc has received licensing for a gold compound platform technology that induces the body's immune system to destroy cancer cells.
A member of The iQ Group Global, iQX Limited is an investment funds management company specialising in the bioscience sector that is committed to eradicating disease through capital investment.
/PRNewswire/ -- OncoTEX Inc. (OncoTEX), a US oncology company and member of The iQ Group Global portfolio, is pleased to announce it has acquired a gold...